Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 4Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 555Neoplasms 501Carcinoma, Non-Small-Cell Lung 416Prostatic Neoplasms 327Colorectal Neoplasms 311Lung Neoplasms 276Neoplasm Metastasis 234Leukemia, Myeloid, Acute 211Ovarian Neoplasms 205Pancreatic Neoplasms 190Multiple Myeloma 185Recurrence 140Squamous Cell Carcinoma of Head and Neck 138Stomach Neoplasms 137Brain Neoplasms 135Melanoma 133Carcinoma, Hepatocellular 132Endometrial Neoplasms 127Glioblastoma 123Triple Negative Breast Neoplasms 116Precursor Cell Lymphoblastic Leukemia-Lymphoma 116Head and Neck Neoplasms 102Hematologic Neoplasms 101Carcinoma, Renal Cell 101Urinary Bladder Neoplasms 97Lymphoma 97Sarcoma 94Glioma 92Esophageal Neoplasms 89Uterine Cervical Neoplasms 85

Interventions

Specimen Handling 1Restraint, Physical 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Endometrioid × 90 days × Clear all
NCT05112601 2026-04-21

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

National Cancer Institute (NCI)

Phase 2 Recruiting
81 enrolled
Gynecologic

Endometrial Neoplasms, Carcinoma, Endometrioid

NCT04291612 2026-04-01

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Memorial Sloan Kettering Cancer Center

Recruiting
1,715 enrolled
Gynecologic

Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡